# Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)

> **NCT01774331** · — · TERMINATED · sponsor: **BriovaRx Infusion Services** · enrollment: 11 (actual)

## Conditions studied

- Intravenous Immunoglobulin (IVIg) Therapy in a Home Infusion Setting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01774331
- **Lead sponsor:** BriovaRx Infusion Services
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01774331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01774331, "Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01774331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
